Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly sales of $93.300 which missed the analyst consensus estimate of $109.250 million by 100.00 percent. This is a 100.00 percent decrease over sales of $116.600 million the same period last year.
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly sales of $93.300 which missed the analyst consensus estimate of $109.250 million by 100.00 percent. This is a 100.00 percent decrease over sales of $116.600 million the same period last year.
Comments